ADHD medication dose too low or too high? How adults and prescribers tell

Many adults on ADHD medication wonder whether the amount they take is right. Maybe the afternoon still falls apart. Maybe the work gets done, but your heart pounds and you cannot eat lunch. This page explains how prescribers think about those two situations, what FDA labels (checked on DailyMed on November 4, 2026) and guidelines say, and what to bring to a visit. It gives no doses of any kind, because those decisions depend on your medication, your health and your prescriber. It is not a reason to take more or less than prescribed.

What "the right dose" means

The UK's NICE guideline gives a useful definition. It says to adjust the dose against symptoms and adverse effects until dose optimization is reached: reduced symptoms, positive behavior change, and improvements in education, employment and relationships, with tolerable adverse effects. So the goal is not the highest amount you can stand, and it is not the lowest number on a chart. The Adderall XR label says to individualize the dose according to the patient's needs and response, and to use the lowest effective dosage.

That definition has two sides, which is why a single sign rarely settles the question. Improvement without tolerable side effects does not meet it. Neither do comfortable days with little change in symptoms.

Why dose adjustment is individual

• Bodies handle these drugs differently. The Strattera (atomoxetine) label reports that total exposure was about 10 times higher in people who are CYP2D6 poor metabolizers than in others. Those adults also had more erectile dysfunction, urinary retention and insomnia in its trials, and the label recommends a longer interval between dose changes for them.
• Other medications matter. The same Strattera instruction applies to people taking a strong CYP2D6 inhibitor. The Adderall XR label says acidifying agents lower amphetamine levels and alkalinizing agents raise them. See ADHD medication drug interactions.
• Health history matters. NICE recommends slower adjustment and more frequent monitoring for people with conditions such as anxiety, depression, bipolar disorder, an eating disorder, substance misuse, cardiac disease or epilepsy.
• Research describes averages. A 2024 meta-analysis of 47 trials in adults, and a 2026 network meta-analysis that included 45 adult trials, looked at dose and outcome. For amphetamines, added benefit leveled off at higher doses while dropouts from side effects kept rising. For methylphenidate, the 2024 study found progressively smaller gains with more dropouts, and the 2026 study found no clear plateau, possibly because data were sparse. The 2026 authors said their results argue against both accepting a poor response without further adjustment and uncritical dose escalation beyond licensed limits. The 2024 authors stressed that results are averages. Neither study can tell you what suits one person.

Labels for Concerta, Vyvanse and Qelbree describe dose changes at about weekly intervals, and the Strattera label allows several weeks at some steps. A judgment after one good or bad day is too early.

Signs coverage may be falling short

No FDA label gives a checklist for this. The examples below turn NICE's definition into everyday questions. They are prompts for a conversation, not diagnostic criteria.

• Symptoms still get in the way at work, at school or at home during the hours the medication should cover.
• You see little change compared with your ratings before treatment.
• Benefit fades at about the same time each day, before the hours you need are over.
• Benefit seemed better at first and has slowly declined.
• Focus is uneven from day to day in a way that tracks sleep, meals or stress.

A dose is only one possible explanation. Fading at a set hour may reflect how long the product lasts. A slow decline may reflect tolerance, a change in the dispensed product, another medication or a harder job. The page on tolerance and wearing off goes through those possibilities. The label's own limit also matters: the Concerta label tells prescribers to discontinue it if ADHD does not improve after appropriate dose changes over a one-month period, so "more" is not always the next step.

Effects that may suggest too much

Labels list these effects as possible reactions to the medication. They do not say that any one of them proves a dose is too high, and some can occur at recommended doses. The Adderall XR label, for example, lists psychotic episodes at recommended doses among reactions reported after approval. Each of these is a reason to contact the prescriber, who decides what it means.

The broader list is in side effects in adults, and mood effects are covered in ADHD medication and mood changes.

Do not change your own dose

This applies in both directions.

• Taking more. Stimulant labels define misuse as using a drug for therapeutic purposes in a way other than prescribed, so taking extra to finish a deadline counts. They warn that misuse and abuse can result in overdose and death, and that the risk rises with higher doses. More is on the page about misuse and addiction risk.
• Taking less or stopping. Stimulant labels list withdrawal signs after abrupt discontinuation or dose reduction following prolonged use, including low mood, fatigue and sleep changes. The Intuniv (guanfacine) label warns of rebound high blood pressure with abrupt stopping. See stopping ADHD medication.
• Timing. Moving a dose is also a change. The Vyvanse label says to avoid afternoon doses because of the potential for insomnia. Raise timing with your prescriber as well.

When it is urgent

• Possible overdose. If you took too much, Medication Guides say to call your health care provider or Poison Help at 1-800-222-1222, or go to the nearest emergency room right away. Stimulant labels describe overdose effects as including racing or irregular heartbeat, high or low blood pressure, agitation, confusion, hallucinations, seizures and dangerously high body temperature. Call 911 if someone is seriously ill, has had a seizure, or cannot be woken.
• Heart symptoms. Medication Guides say to call your provider or go to the nearest emergency room right away for chest pain, shortness of breath or fainting. Call 911 in an emergency.
• Serotonin syndrome. The Adderall XR Medication Guide says this may be life-threatening, and to stop the medication and call your provider or go to the emergency room right away. It lists signs such as agitation, confusion, fast heartbeat, sweating or fever, and muscle twitching.
• Thoughts of suicide. Call or text 988. Call 911 if someone is in immediate danger.

What to track and bring to the visit

NICE encourages people taking ADHD medication to monitor and record adverse effects, for example with a checklist, and recommends considering standard symptom and adverse effect rating scales throughout treatment. It also recommends checking heart rate and blood pressure before and after each dose change and every six months, and weight every six months in adults. Two weeks of simple notes can show more than a memory of your worst day.

1. Timing. When you take the medication, when you feel it start, and when it fades.
2. Function. Two or three things you want treatment to change, rated each day, such as starting tasks, meeting deadlines or following conversations.
3. Side effects. What happened, what time, and how much it got in the way.
4. Sleep and food. Bedtime, wake time, meals skipped and caffeine.
5. Body measurements. Your weight, and pulse and blood pressure if you have a home cuff and your prescriber wants them.
6. Everything else you take. Other prescriptions, over-the-counter products and supplements, plus the name of the manufacturer on your pharmacy label.
7. Any missed or extra doses. Be candid. It changes what the notes mean.

Useful questions include: Does this look like a dose issue, a duration issue or something else? What change would you consider, and what should I watch for? When is the next check-in? Heart monitoring is covered in ADHD medication, heart and blood pressure safety.

Dr. Shershow evaluates and treats adults with ADHD located in New York or New Jersey, including medication management when medication is appropriate. See adult ADHD treatment.